Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) has issued an update.
Lee’s Pharmaceutical Holdings Limited has announced a board meeting scheduled for August 26, 2025, to discuss and approve the unaudited interim results for the first half of 2025, and to consider the recommendation of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company is involved in the development, manufacture, and sale of pharmaceutical products, with a focus on the Hong Kong market.
Average Trading Volume: 1,461,215
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.12B
For detailed information about 0950 stock, go to TipRanks’ Stock Analysis page.